• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.98% Nasdaq Down 0.71%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    7.20 Down 0.25(3.36%) 3:31PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:7.45
    Open:7.38
    Bid:7.22 x 300
    Ask:7.23 x 700
    1y Target Est:12.60
    Beta:1.29
    Next Earnings Date:12-Feb-15CYTK Earnings announcement
    Day's Range:7.00 - 7.44
    52wk Range:3.05 - 13.26
    Volume:179,934
    Avg Vol (3m):513,755
    Market Cap:263.58M
    P/E (ttm):N/A
    EPS (ttm):-0.49
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYTK

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 3.36%263.58M
    BIIBUp 10.76%92.40B
    LGNDDown 1.21%1.13B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.51
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.81
    Quarterly EPS Est (Dec-14) :-0.17
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):-0.61

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditi... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback